![]()
|
|
||||||||
(Received for publication, August 7, 1996, and in revised form, August 26, 1996)
From the Thyroid Unit, Department of Medicine, Beth Israel Hospital
and Harvard Medical School, Boston, Massachusetts 02215
Recently, a family of nuclear co-repressor
proteins (TRACs) have been identified that interact with thyroid
hormone (TR) and retinoic acid receptors to mediate ligand-independent
repression of gene transcription. In this report, we have cloned and
characterized a human TRAC, which when expressed as a truncated protein
lacking its repressing domains, can abolish endogenous cellular TRAC
activity. Use of this inhibitor has uncovered a differential function
of TRACs on negative versus positive thyroid hormone
response elements and has demonstrated the importance of the TR A/B
domain in modulating TRAC function. Thus, isoform-specific functions of
the TR may be mediated by their functional interaction with
co-repressor proteins.
Volume 271, Number 45,
Issue of November 8, 1996
pp. 28516-28520
©1996 by The American Society for Biochemistry and Molecular Biology, Inc.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
N. Tanabe, K. Yoshimura, A. Kimura, Y. Yabuta, and S. Shigeoka Differential Expression of Alternatively Spliced mRNAs of Arabidopsis SR Protein Homologs, atSR30 and atSR45a, in Response to Environmental Stress Plant Cell Physiol., July 1, 2007; 48(7): 1036 - 1049. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. F. R. Velasco, M. Togashi, P. G. Walfish, R. P. Pessanha, F. N. Moura, G. B. Barra, P. Nguyen, R. Rebong, C. Yuan, L. A. Simeoni, et al. Thyroid Hormone Response Element Organization Dictates the Composition of Active Receptor J. Biol. Chem., April 27, 2007; 282(17): 12458 - 12466. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Nygard, N. Becker, B. Demeneix, K. Pettersson, and M. Bondesson Thyroid hormone-mediated negative transcriptional regulation of Necdin expression. J. Mol. Endocrinol., June 1, 2006; 36(3): 517 - 530. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-B. Poirier, G. Hamann, M.-E. Domingue, M. Roy, T. Bardati, and M.-F. Langlois General Receptor for Phosphoinositides 1, a Novel Repressor of Thyroid Hormone Receptor Action that Prevents Deoxyribonucleic Acid Binding Mol. Endocrinol., August 1, 2005; 19(8): 1991 - 2005. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Wan, B. Farboud, and M. L. Privalsky Pituitary Resistance to Thyroid Hormone Syndrome Is Associated with T3 Receptor Mutants that Selectively Impair {beta}2 Isoform Function Mol. Endocrinol., June 1, 2005; 19(6): 1529 - 1542. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Meng, P. Webb, Y.-F. Yang, M. Shuen, A. F. Yousef, J. D. Baxter, J. S. Mymryk, and P. G. Walfish E1A and a nuclear receptor corepressor splice variant (N-CoRI) are thyroid hormone receptor coactivators that bind in the corepressor mode PNAS, May 3, 2005; 102(18): 6267 - 6272. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Cote, S. McNamara, D. Brambilla, A. Bianchini, G. Rizzo, S. V. del Rincon, F. Grignani, C. Nervi, and W. H. Miller Jr Expression of SMRT{beta} promotes ligand-induced activation of mutated and wild-type retinoid receptors Blood, December 15, 2004; 104(13): 4226 - 4235. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Makowski, S. Brzostek, R. N. Cohen, and A. N. Hollenberg Determination of Nuclear Receptor Corepressor Interactions with the Thyroid Hormone Receptor Mol. Endocrinol., February 1, 2003; 17(2): 273 - 286. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Shibusawa, A. N. Hollenberg, and F. E. Wondisford Thyroid Hormone Receptor DNA Binding Is Required for Both Positive and Negative Gene Regulation J. Biol. Chem., January 3, 2003; 278(2): 732 - 738. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Berghagen, E. Ragnhildstveit, K. Krogsrud, G. Thuestad, J. Apriletti, and F. Saatcioglu Corepressor SMRT Functions as a Coactivator for Thyroid Hormone Receptor T3Ralpha from a Negative Hormone Response Element J. Biol. Chem., December 13, 2002; 277(51): 49517 - 49522. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Vasudevan, S. Ogawa, and D. Pfaff Estrogen and Thyroid Hormone Receptor Interactions: Physiological Flexibility by Molecular Specificity Physiol Rev, October 1, 2002; 82(4): 923 - 944. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Cheng, S. Brzostek, S. R. Lee, A. N. Hollenberg, and S. P. Balk Inhibition of the Dihydrotestosterone-Activated Androgen Receptor by Nuclear Receptor Corepressor Mol. Endocrinol., July 1, 2002; 16(7): 1492 - 1501. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. N. Cohen, S. Brzostek, B. Kim, M. Chorev, F. E. Wondisford, and A. N. Hollenberg The Specificity of Interactions between Nuclear Hormone Receptors and Corepressors Is Mediated by Distinct Amino Acid Sequences within the Interacting Domains Mol. Endocrinol., July 1, 2001; 15(7): 1049 - 1061. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Yang and M. L. Privalsky Isoform-Specific Transcriptional Regulation by Thyroid Hormone Receptors: Hormone-Independent Activation Operates through a Steroid Receptor Mode of Coactivator Interaction Mol. Endocrinol., July 1, 2001; 15(7): 1170 - 1185. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. M. Yen Physiological and Molecular Basis of Thyroid Hormone Action Physiol Rev, July 1, 2001; 81(3): 1097 - 1142. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Métivier, F. G. Petit, Y. Valotaire, and F. Pakdel Function of N-Terminal Transactivation Domain of the Estrogen Receptor Requires a Potential {alpha}-Helical Structure and Is Negatively Regulated by the A Domain Mol. Endocrinol., November 1, 2000; 14(11): 1849 - 1871. [Abstract] [Full Text] |
||||
![]() |
R. N. Cohen, A. Putney, F. E. Wondisford, and A. N. Hollenberg The Nuclear Corepressors Recognize Distinct Nuclear Receptor Complexes Mol. Endocrinol., June 1, 2000; 14(6): 900 - 914. [Abstract] [Full Text] |
||||
![]() |
K. Busch, B. Martin, A. Baniahmad, J. A. Martial, R. Renkawitz, and M. Muller Silencing Subdomains of v-ErbA Interact Cooperatively with Corepressors: Involvement of Helices 5/6 Mol. Endocrinol., February 1, 2000; 14(2): 201 - 211. [Abstract] [Full Text] |
||||
![]() |
Z. Yang, S.-H. Hong, and M. L. Privalsky Transcriptional Anti-repression. THYROID HORMONE RECEPTOR beta -2 RECRUITS SMRT COREPRESSOR BUT INTERFERES WITH SUBSEQUENT ASSEMBLY OF A FUNCTIONAL COREPRESSOR COMPLEX J. Biol. Chem., December 24, 1999; 274(52): 37131 - 37138. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Delerive, K. De Bosscher, S. Besnard, W. Vanden Berghe, J. M. Peters, F. J. Gonzalez, J.-C. Fruchart, A. Tedgui, G. Haegeman, and B. Staels Peroxisome Proliferator-activated Receptor alpha Negatively Regulates the Vascular Inflammatory Gene Response by Negative Cross-talk with Transcription Factors NF-kappa B and AP-1 J. Biol. Chem., November 5, 1999; 274(45): 32048 - 32054. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Satoh, T. Ishizuka, T. Monden, N. Shibusawa, T. Hashida, M. Kishi, M. Yamada, and M. Mori Regulation of the Mouse Preprothyrotropin-Releasing Hormone Gene by Retinoic Acid Receptor Endocrinology, November 1, 1999; 140(11): 5004 - 5013. [Abstract] [Full Text] |
||||
![]() |
F. M. Sladek, M. D. Ruse Jr., L. Nepomuceno, S.-M. Huang, and M. R. Stallcup Modulation of Transcriptional Activation and Coactivator Interaction by a Splicing Variation in the F Domain of Nuclear Receptor Hepatocyte Nuclear Factor 4alpha 1 Mol. Cell. Biol., October 1, 1999; 19(10): 6509 - 6522. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Gervois, I. P. Torra, G. Chinetti, T. Grötzinger, G. Dubois, J.-C. Fruchart, J. Fruchart-Najib, E. Leitersdorf, and B. Staels A Truncated Human Peroxisome Proliferator-Activated Receptor {alpha} Splice Variant with Dominant Negative Activity Mol. Endocrinol., September 1, 1999; 13(9): 1535 - 1549. [Abstract] [Full Text] |
||||
![]() |
N. J. McKenna, R. B. Lanz, and B. W. OMalley Nuclear Receptor Coregulators: Cellular and Molecular Biology Endocr. Rev., June 1, 1999; 20(3): 321 - 344. [Abstract] [Full Text] |
||||
![]() |
J. D. Safer, R. N. Cohen, A. N. Hollenberg, and F. E. Wondisford Defective Release of Corepressor by Hinge Mutants of the Thyroid Hormone Receptor Found in Patients with Resistance to Thyroid Hormone J. Biol. Chem., November 13, 1998; 273(46): 30175 - 30182. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. N. Cohen, F. E. Wondisford, and A. N. Hollenberg Two Separate NCoR (Nuclear Receptor Corepressor) Interaction Domains Mediate Corepressor Action on Thyroid Hormone Response Elements Mol. Endocrinol., October 1, 1998; 12(10): 1567 - 1581. [Abstract] [Full Text] |
||||
![]() |
Y. Liu, A. Takeshita, S. Misiti, W. W. Chin, and P. M. Yen Lack of Coactivator Interaction Can Be a Mechanism for Dominant Negative Activity by Mutant Thyroid Hormone Receptors Endocrinology, October 1, 1998; 139(10): 4197 - 4204. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Clifton-Bligh, F. de Zegher, R. L. Wagner, T. N. Collingwood, I. Francois, M. Van Helvoirt, R. J. Fletterick, and V. K. K. Chatterjee A Novel TR{beta} Mutation (R383H) in Resistance to Thyroid Hormone Syndrome Predominantly Impairs Corepressor Release and Negative Transcriptional Regulation Mol. Endocrinol., May 1, 1998; 12(5): 609 - 621. [Abstract] [Full Text] |
||||
![]() |
T. Tagami, P. Kopp, W. Johnson, O. K. Arseven, and J. L. Jameson The Thyroid Hormone Receptor Variant {alpha}2 Is a Weak Antagonist because It Is Deficient in Interactions with Nuclear Receptor Corepressors Endocrinology, May 1, 1998; 139(5): 2535 - 2544. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. P. Olson, B. Sun, and R. J. Koenig Thyroid Hormone Response Element Architecture Affects Corepressor Release from Thyroid Hormone Receptor Dimers J. Biol. Chem., February 6, 1998; 273(6): 3375 - 3380. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Tagami and J. L. Jameson Nuclear Corepressors Enhance the Dominant Negative Activity of Mutant Receptors That Cause Resistance to Thyroid Hormone Endocrinology, February 1, 1998; 139(2): 640 - 650. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Li, C. Leo, D. J. Schroen, and J. D. Chen Characterization of Receptor Interaction and Transcriptional Repression by the Corepressor SMRT Mol. Endocrinol., December 1, 1997; 11(13): 2025 - 2037. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Monden, F. E. Wondisford, and A. N. Hollenberg Isolation and Characterization of a Novel Ligand-dependent Thyroid Hormone Receptor-coactivating Protein J. Biol. Chem., November 21, 1997; 272(47): 29834 - 29841. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-F. Langlois, K. Zanger, T. Monden, J. D. Safer, A. N. Hollenberg, and F. E. Wondisford A Unique Role of the beta -2 Thyroid Hormone Receptor Isoform in Negative Regulation by Thyroid Hormone. MAPPING OF A NOVEL AMINO-TERMINAL DOMAIN IMPORTANT FOR LIGAND-INDEPENDENT ACTIVATION J. Biol. Chem., October 3, 1997; 272(40): 24927 - 24933. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Wilkinson and H. C. Towle Identification and Characterization of the AF-1 Transactivation Domain of Thyroid Hormone Receptor beta 1 J. Biol. Chem., September 19, 1997; 272(38): 23824 - 23832. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Söderström, A. Vo, T. Heinzel, R. M. Lavinsky, W.-M. Yang, E. Seto, D. A. Peterson, M. G. Rosenfeld, and C. K. Glass Differential Effects of Nuclear Receptor Corepressor (N-CoR) Expression Levels on Retinoic Acid Receptor-Mediated Repression Support the Existence of Dynamically Regulated Corepressor Complexes Mol. Endocrinol., June 1, 1997; 11(6): 682 - 692. [Abstract] [Full Text] |
||||
![]() |
S. E. Diamond and A. Gutierrez-Hartmann The Pit-1beta Domain Dictates Active Repression and Alteration of Histone Acetylation of the Proximal Prolactin Promoter J. Biol. Chem., September 29, 2000; 275(40): 30977 - 30986. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Feng, Y. Jiang, P. Meltzer, and P. M. Yen Transgenic Targeting of a Dominant Negative Corepressor to Liver Blocks Basal Repression by Thyroid Hormone Receptor and Increases Cell Proliferation J. Biol. Chem., April 27, 2001; 276(18): 15066 - 15072. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Wu, H. Li, E.-J. Park, and J. D. Chen SMRTe Inhibits MEF2C Transcriptional Activation by Targeting HDAC4 and 5 to Nuclear Domains J. Biol. Chem., June 22, 2001; 276(26): 24177 - 24185. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. N. Collingwood, F. D. Urnov, V. K. K. Chatterjee, and A. P. Wolffe Chromatin Remodeling by the Thyroid Hormone Receptor in Regulation of the Thyroid-stimulating Hormone alpha -Subunit Promoter J. Biol. Chem., August 31, 2001; 276(36): 34227 - 34234. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |